Impact of p53 status on TRAIL-mediated apoptotic and non-apoptotic signaling in cancer cellsAnna Willms, Anna Trauzold|PLoS ONE|2019Cited by 50
The novel TRAIL-receptor agonist APG350 exerts superior therapeutic activity in pancreatic cancer cellsKaren Legler, Anna Trauzold|Cell Death and Disease|2018Cited by 40
TRAIL-receptor 2—a novel negative regulator of p53Anna Willms, Anna Trauzold|Cell Death and Disease|2021Cited by 19
Endogenous TRAIL-R4 critically impacts apoptotic and non-apoptotic TRAIL-induced signaling in cancer cellsA. Rambow, Anna Trauzold|Frontiers in Cell and Developmental Biology|2022Cited by 4